孙艺红

• 1:中日友好医院心脏科

摘要(Abstract)：

<正>2018年8月欧洲心脏病学会(European Society of Cardiology,ESC)及欧洲心胸外科协会(European AssociationforCardio-Thoracic Surgery,EACTS)联合发布2018年血运重建指南~([1])(以下简称2018年指南),于2018年ESC年会上公布,同期在《European Heart Journal》杂

关键词(KeyWords)： 血运重建指南;欧洲心脏病学会;欧洲心胸外科协会;指南解读

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 孙艺红

参考文献(References)：

• [1]Neumann FJ,Sousauva M,Ahlsson A,et al.2018 ESC/EACTSguidelines onmyocardial revascularization.Eur Heart J,2018.[Epub ahead of print]
• [2]Valgimigli M,Bueno H,Byrne RA,et al.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for Cardio-Thoracic Surgery(EACTS).Eur Heart J,2018,39(3):213-260.
• [3]Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC).Eur Heart J,2018,39(2):119-177.
• [4]Amsterdam EA,Wenger NK,Brindis RG,et al.2014 AHA/ACCguideline for the management of patients with non-ST-elevation acute coronary syndromes:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation,2014,130(25):2354-2394.
• [5]Sibbing D,Aradi D,Jacobshagen C,et al.Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention(TROPICAL-ACS):a randomised,open-label,multicentre trial.Lancet,2017,390(10104):1747-1757.
• [6]Vranckx P,Valgimigli M,Jüni P,et al.Ticagrelor plus aspirin for 1 month,followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months,followed by aspirin monotherapy for 12 months af ter implantation of a drug-eluting stent:a multicentre,open-label,randomised superiority trial.Lancet,2018,392(10151):940-949.
• [7]Hahn JY,Song YB,Oh JH,et al.6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome(SMART-DATE):a randomised,open-label,non-inferiority trial.Lancet,2018,391(10127):1274-1284.
• [8]Bonaca MP,Bhatt DL,Cohen M,et al.Long-term use of ticagrelor in patients with prior myocardial infarction.N Engl JMed,2015,372(19):1791-1800.
• [9]Lamberts M,Gislason GH,Olesen JB,et al.Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.J Am Coll Cardiol,2013,62(11):981-989.
• [10]Dewilde WJ,Oirbans T,Verheugt FW,et al.Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention:an open-label,randomised,controlled trial.Lancet,2013,381(9872):1107-1115.
• [11]Gibson CM,Mehran R,Bode C,et al.Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.N Engl J Med,2016,375(25):2423-2434.
• [12]Cannon CP,Bhatt DL,Oldgren J,et al.Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.N Engl JMed,2017,377(16):1513-1524.